Sign In
Buy RDHL
$1.00
-0.0100 (-0.99%)
At Close: Jun 03, 2026
RedHill Biopharma Announces Planned Expansion of Opaganib Global Phase 2/3 COVID-19 Study to the U.S.
07:03am, Tuesday, 23'rd Feb 2021
TEL AVIV, Israel and RALEIGH, NC, Feb. 23, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced its plans to
RedHill (RDHL) Doses First Patient in Phase II/III COVID-19 Study
12:07pm, Friday, 19'th Feb 2021
RedHill (RDHL) doses first patient in phase II/III study of orally-administered RHB-107 (upamostat), an investigational new drug for patients with symptomatic COVID-19 who do not require hospital care
RedHill Biopharma, Cosmo Pharma In Manufacturing Pact for Movantik, RHB-204
01:00pm, Thursday, 18'th Feb 2021
RedHill Biopharma Ltd (NASDAQ: RDHL) has announced agreements with Cosmo Pharmaceuticals NV to manufacture RedHill's largest selling product in the U.S., Movantik, and RHB-204, currently in a Phas
RedHill Biopharma Strengthens Partnership with Cosmo Pharmaceuticals with Manufacturing Agreements for Movantik and RHB-204
07:00am, Thursday, 18'th Feb 2021
TEL AVIV, Israel and RALEIGH, N.C., Feb. 18, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced agreements
RedHill Biopharma says first patient dosed in ground-breaking RHB-107 Phase 2/3 study of coronavirus outpatients
12:05pm, Wednesday, 17'th Feb 2021
RedHill Biopharma Ltd (NASDAQ:RDHL) announced Wednesday that the first patient was dosed in its US Phase 2/3 study of orally-administered RHB-107 (upamostat), an investigational new drug for patients
These 2 Coronavirus Stocks Could Soar in the First Half of 2021
06:20am, Tuesday, 26'th Jan 2021
This could be a key year for these companies' treatment candidates.
RedHill Biopharma Announces Closing of $25 Million Bought Deal Offering
02:13pm, Thursday, 14'th Jan 2021
TEL AVIV, Israel and RALEIGH, N.C., Jan. 14, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the closing
Why RedHill Biopharma Stock Is Tanking Today
12:56pm, Tuesday, 12'th Jan 2021
The drugmaker more than doubled the size of its planned public stock offering.
RedHill Biopharma Announces $10 Million Bought Deal Offering
04:35pm, Monday, 11'th Jan 2021
TEL AVIV, Israel and RALEIGH, N.C., Jan. 11, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has
RedHill's (RDHL) RHB-204 Gets FDA Fast Track Designation
10:32am, Thursday, 07'th Jan 2021
RedHill (RDHL) gets Fast Track status from the FDA for the treatment of nontuberculous mycobacteria (NTM) disease.
RedHill (RDHL) COVID-19 Drug Shows Promise in Mid-Stage Study
10:41am, Monday, 04'th Jan 2021
RedHill's (RDHL) opaganib achieves greater improvement in reducing oxygen requirement compared to placebo in a phase II study evaluating it in patients hospitalized with COVID-19 pneumonia.
Is the Options Market Predicting a Spike in RedHill Biopharma (RDHL) Stock?
12:02pm, Monday, 28'th Dec 2020
Investors need to pay close attention to RedHill Biopharma (RDHL) stock based on the movements in the options market lately.
RedHill: A Slow And Steady Climb Towards Biopharma Success
02:29am, Tuesday, 08'th Dec 2020
RedHill has a stable line of approved, marketed and pipeline products. Its cash balance is a little low.
Do Hedge Funds Love RedHill Biopharma Ltd (RDHL)?
04:53pm, Friday, 27'th Nov 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 817 13F
RedHill Biopharma Expands U.S.-Based Manufacturing Capacity of Opaganib for COVID-19
10:36am, Wednesday, 25'th Nov 2020
TEL AVIV, Israel and RALEIGH, N.C., Nov. 25, 2020 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced partnership
